ArticleCell reports. Medicine2024

Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia.

Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.